Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.40
Delayed Data
As of 3:59pm ET
 -0.06 / -4.11%
Today’s Change
1.02
Today|||52-Week Range
1.79
+19.66%
Year-to-Date
No recent news for Lineage Cell Therapeutics Inc.

Today’s Trading

Previous close1.46
Today’s open1.44
Day’s range1.39 - 1.44
Volume217,114
Average volume (3 months)377,918
Market cap$246.7M
Data as of 3:59pm ET, 03/27/2023

Growth & Valuation

Earnings growth (last year)+40.84%
Earnings growth (this year)-10.48%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+277.39%
P/E ratioNM
Price/Sales13.51
Price/Book3.36

Competitors

----
XOMAXOMA Corp-0.46-2.11%
MGTXMeiraGTx Holdings PL...+0.03+0.59%
KODKodiak Sciences Inc+0.11+2.29%
Data as of 3:59pm ET, 03/27/2023

Financials

Next reporting dateMay 11, 2023
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$14.7M
Annual profit (last year)-$26.3M
Net profit margin-178.69%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Carlsbad, California

Forecasts